US industry association refreshes its image
2 June 2020
The US Consumer Healthcare Products Association (CHPA) has refreshed its image with a new logo, tagline and brand narrative.
Industry News - Tag: CHPA
You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
People in brief | CHPA, Boiron, Angelini
15 April 2020
The US Consumer Healthcare Products Association (CHPA) has elected a new chair, Boiron has announced a change to its board and Angelini Pharma has made a promotion.
People in brief | CHPA, HMPC, GlaxoSmithKline
20 March 2020
The US Consumer Healthcare Products Association (CHPA) has created the new position of vice president for scientific affairs and dietary supplements, Europe’s Committee for Herbal Medicinal Products (HMPC) has elected a new chair, and GlaxoSmithKline (GSK) has a new non-executive director.
Regulatory in brief | Belgium, France, monographs, US FDA
17 December 2019
Belgium is banning combination cough and cold medicines, France is seeking to ensure safe use of vasoconstrictors, the US Senate has passed key OTC legislation, and the new commissioner of the US Food and Drug Administration (FDA) has been confirmed.
People in brief | Abbott, Unilever, CHPA, Teva
15 November 2019
Abbott, Unilever, the US Consumer Healthcare Products Association (CHPA) and Teva Pharmaceutical have all announced people changes.
Industry in brief | CBD, Probi, Thornton & Ross
9 October 2019
The US dietary supplement industry wants rapid action on cannabidiol (CBD) products, Probi has revised its 2019 sales forecast and Thornton & Ross is expanding its capacity.
People in brief | BioGaia, EMA, CHPA, Bayer
4 October 2019
BioGaia, the European Medicines Agency (EMA), the US Consumer Healthcare Products Association (CHPA) and Bayer have all announced people changes.
US CHPA adds director of health policy to team
14 August 2019
The US Consumer Healthcare Products Association (CHPA) has expanded its team with a director of health policy who will focus on promoting OTC values to health insurers, health providers and employers.
Regulators must move quickly on CBD regulation
Premium
7 June 2019
The US Food and Drug Administration (FDA) needs to "step up very quickly" with regulation for cannabidiol (CBD) products, says Scott Melville, president and chief executive officer of the US Consumer Healthcare Products Association (CHPA). According to Melville, the current situation in the US is li...
US FDA considers ways of regulating CBD
9 April 2019
The US Food and Drug Administration (FDA) is holding a public hearing on potential ways of regulating products containing cannabis and cannabis-derived compounds including cannabidiol (CBD).